EXHIBIT 31.1

                                  CERTIFICATION

I, Robert Prokos, certify that:

1. I have reviewed this quarterly  report on Form 10-QSB of HealthRenu  Medical,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of HealthRenu Medical,
Inc. as of, and for, the periods presented in this report;

4. I am responsible for  establishing  and maintaining  disclosure  controls and
procedures  (as defined in  Exchange  Act Rules  13a-15(e)  and  15d-15(e))  for
HealthRenu Medical, Inc. and have:

      a)  Designed  such  disclosure  controls  and  procedures,  or caused such
      disclosure controls and procedures to be designed under my supervision, to
      ensure that material  information  relating to HealthRenu  Medical,  Inc.,
      including  its  consolidated  subsidiaries,  is made known to me by others
      within those entities, particularly during the period in which this report
      is being prepared;

      b)  Paragraph  omitted  in  accordance  with SEC  transition  instructions
      contained in SEC Release No. 33-8238;

      c) Evaluated the  effectiveness of HealthRenu  Medical,  Inc.'s disclosure
      controls and procedures and presented in this report my conclusions  about
      the effectiveness of the disclosure controls and procedures, as of the end
      of the period covered by this report based on such evaluation; and

      d)  Disclosed  in this  report any change in  HealthRenu  Medical,  Inc.'s
      internal control over financial  reporting that occurred during HealthRenu
      Medical,  Inc.'s most recent fiscal quarter that has materially  affected,
      or is reasonably likely to materially affect,  HealthRenu Medical,  Inc.'s
      internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over
financial  reporting,  to  HealthRenu  Medical,  Inc.'s  auditors  and the audit
committee  of  HealthRenu  Medical,   Inc.'s  board  of  directors  (or  persons
performing the equivalent functions):

      a) All significant  deficiencies and material  weaknesses in the design or
      operation  of  internal   control  over  financial   reporting  which  are
      reasonably likely to adversely affect HealthRenu  Medical,  Inc.'s ability
      to record, process, summarize and report financial information; and

      b) Any fraud,  whether or not material,  that involves management or other
      employees  who  have a  significant  role in  HealthRenu  Medical,  Inc.'s
      internal control over financial reporting.

Date:  August 15, 2005


                                   By: /s/Robert Prokos
                                   ---------------------------
                                   Robert Prokos,
                                   Chief Executive Officer and
                                   Principal Financial Officer